Cargando…

An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET

BACKGROUND: The standardized uptake value (SUV) is the nearly exclusive means for quantitative evaluation of clinical [18F-]fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) whole body investigations. However, the SUV methodology has well-known shortcomings. In this context, it has bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hofheinz, Frank, Bütof, Rebecca, Apostolova, Ivayla, Zöphel, Klaus, Steffen, Ingo G., Amthauer, Holger, Kotzerke, Jörg, Baumann, Michael, van den Hoff, Jörg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775714/ https://www.ncbi.nlm.nih.gov/pubmed/26936768 http://dx.doi.org/10.1186/s13550-016-0174-y

Ejemplares similares

Comparative evaluation of SUV, tumor-to-blood standard uptake ratio (SUR), and dual time point measurements for assessment of the metabolic uptake rate in FDG PET
por: Hofheinz, Frank, et al.
Publicado: (2016)

The association of tumor-to-background ratios and SUVmax deviations related to point spread function and time-of-flight F18-FDG-PET/CT reconstruction in colorectal liver metastases
por: Rogasch, Julian MM, et al.
Publicado: (2015)

A convolutional neural network for fully automated blood SUV determination to facilitate SUR computation in oncological FDG-PET
por: Nikulin, Pavel, et al.
Publicado: (2020)

Monitoring scanner calibration using the image-derived arterial blood SUV in whole-body FDG-PET
por: Maus, Jens, et al.
Publicado: (2018)

The PET-derived tumor-to-blood standard uptake ratio (SUR) is superior to tumor SUV as a surrogate parameter of the metabolic rate of FDG
por: van den Hoff, Jörg, et al.
Publicado: (2013)

Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET
por: Hofheinz, Frank, et al.
Publicado: (2019)

Quantitative assessment of the asphericity of pretherapeutic FDG uptake as an independent predictor of outcome in NSCLC
por: Apostolova, Ivayla, et al.
Publicado: (2014)

Dual time point based quantification of metabolic uptake rates in (18)F-FDG PET
por: den Hoff, Jörg van, et al.
Publicado: (2013)

Combination of tumor asphericity and an extracellular matrix-related prognostic gene signature in non-small cell lung cancer patients
por: Zschaeck, Sebastian, et al.
Publicado: (2023)

Impact of the size of the normal database on the performance of the specific binding ratio in dopamine transporter SPECT
por: Schmitz-Steinkrüger, Helen, et al.
Publicado: (2020)

A method for model-free partial volume correction in oncological PET
por: Hofheinz, Frank, et al.
Publicado: (2012)

Correction of scan time dependence of standard uptake values in oncological PET
por: van den Hoff, Jörg, et al.
Publicado: (2014)

The influence of different signal-to-background ratios on spatial resolution and F18-FDG-PET quantification using point spread function and time-of-flight reconstruction
por: Rogasch, Julian MM, et al.
Publicado: (2014)

Noninvasive assessment and quantification of tumor vascularization using [18F]FDG-PET/CT and CE-CT in a tumor model with modifiable angiogenesis—an animal experimental prospective cohort study
por: Mirus, Martin, et al.
Publicado: (2019)

Suitability of bilateral filtering for edge-preserving noise reduction in PET
por: Hofheinz, Frank, et al.
Publicado: (2011)

Asphericity of tumor FDG uptake in non-small cell lung cancer: reproducibility and implications for harmonization in multicenter studies
por: Rogasch, Julian M. M., et al.
Publicado: (2020)

Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma
por: Rogasch, Julian M. M., et al.
Publicado: (2018)

Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patients
por: Bandurska-Luque, Anna, et al.
Publicado: (2019)

Quantitative accuracy of attenuation correction in the Philips Ingenuity TF whole-body PET/MR system: a direct comparison with transmission-based attenuation correction
por: Schramm, Georg, et al.
Publicado: (2012)

Erratum to: Quantitative accuracy of attenuation correction in the Philips Ingenuity TF whole-body PET/MR system: a direct comparison with transmission-based attenuation correction
por: Schramm, Georg, et al.
Publicado: (2014)

Nerve Sheath Tumors in Neurofibromatosis Type 1: Assessment of Whole-Body Metabolic Tumor Burden Using F-18-FDG PET/CT
por: Salamon, Johannes, et al.
Publicado: (2015)

Comparison of image quality and spatial resolution between (18)F, (68)Ga, and (64)Cu phantom measurements using a digital Biograph Vision PET/CT
por: Braune, Anja, et al.
Publicado: (2022)

Prognostic Value of Pretherapeutic Primary Tumor MTV from [(18)F]FDG PET in Radically Treated Cervical Cancer Patients
por: Cegla, Paulina, et al.
Publicado: (2021)

Longitudinal and Multimodal Radiomics Models for Head and Neck Cancer Outcome Prediction
por: Starke, Sebastian, et al.
Publicado: (2023)

The association of intra-therapeutic heterogeneity of somatostatin receptor expression with morphological treatment response in patients undergoing PRRT with [(177)Lu]-DOTATATE
por: Wetz, Christoph, et al.
Publicado: (2019)

A convolutional neural network with self-attention for fully automated metabolic tumor volume delineation of head and neck cancer in [Formula: see text] F]FDG PET/CT
por: Nikulin, Pavel, et al.
Publicado: (2023)

FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value
por: Hussien, Amr Elsayed M., et al.
Publicado: (2015)

[(68)Ga]Ga-PSMA-11 PET before and after initial long-term androgen deprivation in patients with newly diagnosed prostate cancer: a retrospective single-center study
por: Hoberück, Sebastian, et al.
Publicado: (2020)

Influence of rigid coregistration of PET and CT data on metabolic volumetry: a user’s perspective
por: Steffen, Ingo G, et al.
Publicado: (2013)

Software-assisted dosimetry in peptide receptor radionuclide therapy with (177)Lutetium-DOTATATE for various imaging scenarios
por: Kupitz, Dennis, et al.
Publicado: (2017)

Reconstructed spatial resolution and contrast recovery with Bayesian penalized likelihood reconstruction (Q.Clear) for FDG-PET compared to time-of-flight (TOF) with point spread function (PSF)
por: Rogasch, Julian M., et al.
Publicado: (2020)

Impact of Blood Parameters and Normal Tissue Dose on Treatment Outcome in Esophageal Cancer Patients Undergoing Neoadjuvant Radiochemotherapy
por: Bütof, Rebecca, et al.
Publicado: (2022)

In vivo confirmation of altered hepatic glucose metabolism in patients with liver fibrosis/cirrhosis by (18)F-FDG PET/CT
por: Verloh, Niklas, et al.
Publicado: (2018)

Implications of Ambient Glucose Variation on the Target-to-Background Ratio of Hepatic Tumors By (18)FDG-PET Imaging
por: Jolepalem, Prashant, et al.
Publicado: (2014)

Elevated tumor-to-liver uptake ratio (TLR) from (18)F–FDG-PET/CT predicts poor prognosis in stage IIA colorectal cancer following curative resection
por: Huang, Jun, et al.
Publicado: (2017)

Local Control after Locally Ablative, Image-Guided Radiotherapy of Oligometastases Identified by Gallium-68-PSMA-Positron Emission Tomography in Castration-Sensitive Prostate Cancer Patients (OLI-P)
por: Hölscher, Tobias, et al.
Publicado: (2022)

18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization
por: Zschaeck, Sebastian, et al.
Publicado: (2022)

PET/MRI Imaging in High-Risk Sarcoma: First Findings and Solving Clinical Problems
por: Schuler, Markus K., et al.
Publicado: (2013)

Asphericity derived from [(18)F]FDG PET as a new prognostic parameter in cervical cancer patients
por: Cegla, Paulina, et al.
Publicado: (2023)

Increased neutrophil lymphocyte ratio and platelet lymphocyte ratio in malignant parotid tumors()
por: Kuzucu, İhsan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kdt495kja5i75tbcg59u5b2q5f